Trial intelligence / Profile preview

Phase III randomized open-label trial of bortezomib-based induction and maintenance in newly diagnosed symptomatic multiple myeloma patients older than 65 years

2005-001111-21Phase 3Completed

Sponsor

Fundación PETHEMA

Start

Oct 2005

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules

Countries

1